NASDAQ:MRTX
Delisted

Mirati Therapeutics Stock News

etoro logo Buy MRTX
*Your capital is at risk
$58.70
+0 (+0%)
At Close: Apr 19, 2024
JonesTrading analyst Soumit Roy reiterated a Buy rating on Mirati Therapeutics ( MRTX – Research Report ) today and set a price target of $130.00 . The company’s shares closed last Monday at $93.7
Charles Baum has been the CEO of Mirati Therapeutics, Inc. (NASDAQ:MRTX) since 2012. First, this article will compare...
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors o
NEW YORK, April 20, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Mirati Therapeutics,.
Goldman Sachs Group began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX) in a research report sent to investors on Thursday, Benzinga reports. The firm issued a buy rating and a $151.00 price
BioDelivery Sciences International (NASDAQ:BDSI) and Mirati Therapeutics (NASDAQ:MRTX) are both medical companies, but which is the better stock? We will compare the two companies based on the strengt
Stocks closed down on Wednesday as the economic numbers are starting to show just how weak the economy is becoming, but a drop in jobless claims (to 5.25 million) has allowed stocks to rise less than
ACADIA Pharmaceuticals (NASDAQ:ACAD) initiated with a Buy rating and a $60 (33% upside) price target at Jefferies.eHealth (NASDAQ:EHTH) initiated with an Overweight rating and a $150 (26% upside) pric
Mirati Therapeutics initiated with a Buy at Goldman Sachs Goldman Sachs MRTX
Bank of America Corp DE reduced its holdings in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 46.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 47,041
Alliancebernstein L.P. boosted its stake in Mirati Therapeutics Inc (NASDAQ:MRTX) by 1.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Mirati Therapeutics Inc (NASDAQ:MRTX)’s stock price was up 7.5% during trading on Monday . The stock traded as high as $82.42 and last traded at $78.95, approximately 560,624 shares changed hands du
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Franklin Resources Inc. lessened its holdings in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 6.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securit
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE